Related Experiment Video
Updated: Apr 16, 2026
04:53
A Clinical Trial Assessing the Safety, Efficacy, and Delivery of Olive-Oil-Based Three-Chamber Bags for Parenteral Nutrition
Published on: September 20, 2019
11.5K
Data fraud in clinical trials
Stephen L George1, Marc Buyse2
1Department of Biostatistics & Bioinformatics, Duke University School of Medicine, Durham, NC 27705-3833, USA.
Clinical Investigation
|March 3, 2015
Summary
Data fraud in clinical trials is a significant concern, with undetected cases likely. Central statistical monitoring offers a cost-effective method for early detection, improving overall data quality and identifying fraud missed by traditional site monitoring.
Area of Science:
- Clinical research
- Data integrity
- Regulatory science
Background:
- Recent high-profile cases highlight the issue of data fabrication and falsification in clinical trials.
- Undetected or unreported instances of data fraud are suspected to be more prevalent than publicly known.
Purpose of the Study:
- To review the incidence of data fraud in clinical trials.
- To examine motivations and contributing factors behind data fraud.
- To discuss methods for early detection of data fraud through central statistical monitoring.
Main Methods:
- Review of existing evidence on clinical trial data fraud.
- Analysis of prominent cases of data fabrication and falsification.
- Discussion of central statistical monitoring as a data quality tool.
Main Results:
- Evidence suggests data fraud occurs in clinical trials, with potential for widespread undetected cases.
- Understanding motivations and contributing factors is crucial for prevention.
- Central statistical monitoring can effectively detect data fraud missed by on-site methods.
Conclusions:
- Central statistical monitoring is a valuable, cost-effective strategy for early detection of data fraud in clinical trials.
- Implementing these monitoring procedures enhances overall data quality and reliability.
- Proactive monitoring is essential to maintain the integrity of clinical trial data.
Related Concept Videos
01:16Clinical Trials
11.2K
Clinical trials are prospective experimental studies conducted on humans to determine the safety and efficacy of treatments, drugs, diet methods, and medical devices. Using statistics in clinical trials enables researchers to derive reasonable and accurate conclusions from the collected data, allowing them to make wise decisions in uncertain situations. In medical research, statistical methods are crucial for preventing errors and bias.
There are four phases in a clinical trial. A phase one...
There are four phases in a clinical trial. A phase one...
11.2K
01:11Clinical Trials: Overview
5.5K
Clinical development focuses on how the drug will interact with the human body and encompasses four key phases of clinical trials, each serving a specific purpose in assessing the safety and effectiveness of new drugs. These phases overlap and build upon one another. Phase I involves a small group of healthy volunteers (typically 20-80 individuals) or, in cases where significant toxicity is expected, patients with the targeted disease, such as cancer or AIDS. The volunteers are tested for...
5.5K
01:11Blinding
4.1K
Blinding is a commonly used method of not telling participants which treatment a subject is receiving. Blinding is a critical part of a randomized control trial or RCT. It reduces the bias that affects the results. In an RCT, blinding is used in the form of a placebo. A placebo effect occurs when untreated subjects falsely believe they have received the treatment and report improved symptoms. A placebo or a dummy treatment is administered to subjects to negate the bias caused by such an effect.
4.1K
01:23Types of Biopharmaceutical Studies: Controlled and Non-Controlled Approaches
579
Biopharmaceutical studies constitute a vital field aiming to enhance drug delivery methods and refine therapeutic approaches, drawing upon diverse interdisciplinary knowledge. In research methodologies, the choice between controlled and non-controlled studies significantly influences the study's reliability and accuracy.
Non-controlled studies, commonly employed for initial exploration, lack a control group, rendering them susceptible to biases and external influences. In contrast,...
Non-controlled studies, commonly employed for initial exploration, lack a control group, rendering them susceptible to biases and external influences. In contrast,...
579
02:07Blind Procedures
13.9K
Ideally, the people who observe and record the children’s behavior are unaware of who was assigned to the experimental or control group, in order to control for experimenter bias. Experimenter bias refers to the possibility that a researcher’s expectations might skew the results of the study. Remember, conducting an experiment requires a lot of planning, and the people involved in the research project have a vested interest in supporting their hypotheses. If the observers knew which...
13.9K
01:15Bioavailability Study Design: Healthy Subjects Versus Patients
228
Bioavailability studies are essential for evaluating a drug's therapeutic efficacy and understanding its absorption patterns under various physiological conditions. Conducting such studies on target patient populations provides more relevant data by simulating real-world disease states. However, practical challenges often necessitate the use of young, healthy adult volunteers as study subjects.Patients may exhibit altered drug absorption patterns due to the effects of the disease itself,...
228